Thomas Blaschke is an AI-driven chemoinformatics researcher and leader with nine years’ experience applying deep learning to small-molecule de novo design and multi-target drug discovery. He has progressed from PhD work in Big Data Analysis in Chemistry (Marie Skłodowska-Curie BIGCHEM) to senior research and director roles at Rahko and Odyssey Therapeutics, and now leads AI algorithms at Xyme in London. Thomas blends academic rigor with industry impact, having shepherded tech through acquisition and translated generative models into pragmatic drug-discovery workflows. He believes in pairing AI with robotic automation to accelerate safer medicines, and brings hands-on expertise in AI/ML for drug discovery along with a background in life science informatics and biomedical sciences. A detail sometimes overlooked: his career arc reflects not only model development but successful technology maturation and commercial integration in the biotech sector.
9 years of coding experience
5 years of employment as a software developer
Master of Science - MS, Life Science Informatics, Master of Science - MS, Life Science Informatics at The University of Bonn
Contributions:6 commits, 1 push, 1 comment in 2 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Thomas Blaschke - Associate Director, AI Algorithms